Eric M. Reiman, M.D., serves as deputy editor of this section, which encourages scientific studies of Alzheimer’s disease, promotes the optimal care of patients, and helps to keep the psychiatric community informed of the latest scientific and clinical developments. See our information on submitting a manuscript to this section.
Gender Differences in Clinical Manifestations and Outcomes Among Hospitalized Patients With Behavioral and Psychological Symptoms of Dementia
Association Between White Matter Hyperintensity Severity and Cognitive Impairment According to the Presence of the Apolipoprotein E (APOE) e4 Allele in the Elderly: Retrospective Analysis of Data From the CREDOS Study
Long-Term Observation of a Multicomponent Cognitive Intervention in Mild Cognitive Impairment
A Meta-Analytic Review of Polyunsaturated Fatty Acid Compositions in Dementia
Efficacy of Nonpharmacologic Interventions for Agitation in Advanced Dementia: A Randomized, Placebo-Controlled Trial
The Relationships of Environment and Personal Characteristics to Agitated Behaviors in Nursing Home Residents With Dementia
Metabolism of Amyloid-ß Protein May Be Affected in Depression
Effect of Second-Generation Antipsychotics on Caregiver Burden in Alzheimer’s Disease
Prediction of Alzheimer’s Disease Using Midregional Proadrenomedullin and Midregional Proatrial Natriuretic Peptide: A Retrospective Analysis of 134 Patients With Mild Cognitive Impairment
Persistent Depressive Symptoms and Cognitive Function in Late Midlife: The Whitehall II Study.
Abnormal Integrity of Long Association Fiber Tracts Is Associated With Cognitive Deficits in Patients With Remitted Geriatric Depression: A Cross-Sectional, Case-Control Study.
Cognizance of Cognition in Older Primary Care Patients With Depression and Restraining Restraint and Agitation in Nursing Home Residents With Dementia.
Depression Predicts Cognitive Disorders in Older Primary Care Patients.
The Effect of Staff Training on Agitation and Use of Restraint in Nursing Home Residents With Dementia: A Single-Blind, Randomized Controlled Trial.
Introduction. Untangling the Roles of Antidepressants and Mood Stabilizers in the Treatment of Alzheimer's Disease.
Effect of a Serotonin Reuptake Inhibitor on Irritability, Apathy, and Psychotic Symptoms in Patients With Alzheimer's Disease.
Commentary. Can Lithium or Valproate Untie Tangles in Alzheimer's Disease?
Lithium Trial in Alzheimer's Disease: A Randomized, Single-Blind, Placebo-Controlled, Multicenter 10-Week Study.
Commentary. Grumpy Old Men (and Women): Mere Hassle or Meaningful Clinical Evidence?
Mild Behavioral Impairment and Risk of Dementia: A Prospective Cohort Study of 358 Patients
Entering the Era of High-Density Genome-Wide Association Studies
A High-Density Whole-Genome Association Study Reveals That APOE Is the Major Susceptibility Gene for Sporadic Late-Onset Alzheimer's Disease
Clinical Trials and Tribulations
Study Design Factors and Patient Demographics and Their Effect on the Decline of Placebo-Treated Subjects in Randomized Clinical Trials in Alzheimer's Disease
Antiaggressive Effect of Cyproterone Versus Haloperidol in Alzheimer's Disease: A Randomized Double-Blind Pilot Study
Helping Families With End-of-Life Care in Alzheimer's Disease
The Non-Alzheimer Dementias
A Review of the Non-Alzheimer Dementias
A 100-Year Update on Alzheimer's Disease and Related Disorders
Alzheimer's Disease A Century Later
The Genetic, Transcriptomic, and Proteomic Study of Alzheimer's Disease
Genetics, Transcriptomics, and Proteomics of Alzheimer's Disease
Genetics, Cholesterol, and the Risk of Alzheimer's Disease
A Cluster of Cholesterol-Related Genes Confers Susceptibility for Alzheimer's Disease